Clinical Trials Browser

Infusions, Intravenous × Clear all

NCT07530445 2026-04-15

Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT07108114 2026-02-23

SLV-324 Treatment of Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Metastatic Solid Tumors

NCT07286253 2025-12-16

QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial

Phase 2 Recruiting

Neoadjuvant Treatment for Locally Advanced Cervical Cancer

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Metastatic Solid Tumors

NCT07243691 2025-11-24

Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06490718 2025-09-08

Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery

Phase NA Completed

Breast Neoplasms

NCT04099797 2025-09-04

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Phase 1 Recruiting

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma, Neoplasms, Germ Cell and Embryonal, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT06505837 2025-08-28

JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）

Phase 3 Active not recruiting

Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer

NCT03850574 2025-08-26

TUSCANY

Phase 1/2 Recruiting

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT05894889 2025-07-23

Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07024030 2025-06-17

DGPR1008

Phase 2 Completed

Prostate Cancer Patients Undergoing Radical Prostatectomy

NCT03238248 2024-11-04

Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors

Phase 2 Completed

71 enrolled 13 charts

Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT04477772 2024-05-16

A Phase I Clinical Study of JS004 in Subjects With Recurrent/Refractory Malignant Lymphoma of China

Phase 1 Completed

Lymphoma

NCT06330337 2024-03-26

Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma

Phase 3 Recruiting

Glioma

NCT06232694 2024-01-31

Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05053308 2023-08-07

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Phase NA Withdrawn

Cancer Pain, Breakthrough Pain

NCT05798533 2023-07-10

Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)

Phase 1 Unknown

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05798546 2023-04-04

Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

Phase 1 Unknown

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05448599 2023-03-15

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05524194 2022-09-01

6MW3511 in Patients With Advanced Solid Tumor

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors

NCT05001451 2022-07-20

Study of GDX012 in Patients With MRD Positive AML

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05048160 2022-05-09

A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm

Phase 1/2 Unknown

Advanced Malignant Neoplasm

NCT04866498 2021-04-29

Pharmacotherapy Personalization of Cancer Patients

Head and Neck Neoplasms

NCT01023958 2017-11-22

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Phase 2 Completed

50 enrolled 29 charts

Neoplasms

NCT00399035 2016-12-28

HORIZON II

Phase 3 Completed

1,254 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms